Applied Therapeutics, Inc. Gains 68.82%

Wed, Sep 18, 2024 at 05:30 PM
Applied Therapeutics, Inc. Gains 68.82%

Applied Therapeutics, Inc. (APLT:NASDAQ) shot up at $7.85, a gain of 68.8%. On Tue, Sep 17, 2024, APLT:NASDAQ hit a New 2-Week Low of $4.65. The stock got featured on our News Catalysts scanner on Wed, Sep 18, 2024 at 11:16 AM in the 'BIOTECH' category. From Tue, Sep 03, 2024, the stock recorded 30.00% Up Days and 27.27% Green Days

About Applied Therapeutics, Inc. (APLT:NASDAQ)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.